Shinya Ohashi

4.4k total citations · 1 hit paper
72 papers, 2.3k citations indexed

About

Shinya Ohashi is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Shinya Ohashi has authored 72 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 23 papers in Pulmonary and Respiratory Medicine and 22 papers in Molecular Biology. Recurrent topics in Shinya Ohashi's work include Esophageal Cancer Research and Treatment (15 papers), Cancer Cells and Metastasis (9 papers) and Alcohol Consumption and Health Effects (9 papers). Shinya Ohashi is often cited by papers focused on Esophageal Cancer Research and Treatment (15 papers), Cancer Cells and Metastasis (9 papers) and Alcohol Consumption and Health Effects (9 papers). Shinya Ohashi collaborates with scholars based in Japan, United States and Vietnam. Shinya Ohashi's co-authors include Manabu Muto, Yusuke Amanuma, Osamu Kikuchi, Shin’ichi Miyamoto, Tomoyuki Gotō, Hiroshi Nakagawa, Andres J. Klein–Szanto, Mitsuteru Natsuizaka, J. Alan Diehl and Tsutomu Chiba and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Shinya Ohashi

68 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma

2015 416 citations Shinya Ohashi, Shin’ichi Miyamoto et al. Gastroenterology profile →

Peers

Countries citing papers authored by Shinya Ohashi

Since Specialization

Citations

This map shows the geographic impact of Shinya Ohashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shinya Ohashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shinya Ohashi more than expected).

Fields of papers citing papers by Shinya Ohashi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shinya Ohashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shinya Ohashi. The network helps show where Shinya Ohashi may publish in the future.

Co-authorship network of co-authors of Shinya Ohashi

This figure shows the co-authorship network connecting the top 25 collaborators of Shinya Ohashi. A scholar is included among the top collaborators of Shinya Ohashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shinya Ohashi. Shinya Ohashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nivolumab with definitive chemoradiotherapy for oesophageal squamous cell carcinoma (NOBEL): a multicentre, single-arm, phase 2 feasibility trial 2025 ·EClinicalMedicine ·(unknown), (unknown), (unknown), Shinya Ohashi, (unknown), Akinori Watanabe, Yusuke Amanuma, Keiko Minashi, (unknown), (unknown), (unknown), (unknown), Harue Tada, (unknown), (unknown)	0
2	Effect of nivolumab combined with definitive chemoradiotherapy on response rate for esophageal cancer: An immune active intrinsic subtype could be its biomarker—The NOBEL trial. 2024 ·Journal of Clinical Oncology ·Manabu Muto, (unknown), Katsuyuki Sakanaka, (unknown), Shinya Ohashi, Akinori Watanabe, Chikatoshi Katada, Yusuke Amanuma, Keiko Minashi, Ken Kato, Takashi Kojima, Kengo Nagashima, (unknown), Harue Tada, (unknown), Hiroki Sasaki	1
3	Abstract 4659: A genome-wide CRISPR screen identifies ARID1A as a potential resistance marker of IDH1 inhibitor in IDH1-mutant cholangiocarcinoma cell 2024 ·Cancer Research ·Tomohiro Kondo, Osamu Kikuchi, (unknown), Yukie Nakai, (unknown), Yang Cao, (unknown), Yuki Kondo, (unknown), Yoshihiro Yamamoto, Tomoki Saito, (unknown), Atsushi Yamada, Masashi Kanai, Shinya Ohashi, Manabu Muto	0
4	ALDH2 dysfunction and alcohol cooperate in cancer stem cell enrichment 2023 ·Carcinogenesis ·(unknown), Masataka Shimonosono, (unknown), Norihiro Matsuura, Shinya Ohashi, Manabu Muto, Andres J. Klein–Szanto, J. Alan Diehl, Che‐Hong Chen, Daria Mochly‐Rosen, Kenneth I. Weinberg, Hiroshi Nakagawa	8
5	Expression molecular subtype as a predictor of outcomes of chemoradiotherapy for esophageal cancer. 2023 ·Journal of Clinical Oncology ·Manabu Muto, Keiko Minashi, Tomonori Yano, Yusuke Amanuma, Ryu Ishihara, Akinori Watanabe, Chikatoshi Katada, Tomoki Yamatsuji, Kayoko Matsushima, Hisashi Doyama, (unknown), Yasumasa Nishimura, Katsuyuki Sakanaka, Shigeru Tsunoda, Shinya Ohashi, (unknown), Harue Tada, Ryuji Uozumi, Kengo Nagashima, Hiroki Sasaki	1
6	Clinicopathological and molecular characterization of deficient mismatch repair colorectal cancer 2022 ·Human Pathology ·Atsushi Yamada, Yoshihiro Yamamoto, Sachiko Minamiguchi, Mayumi Kamada, (unknown), Shinya Ohashi, Hiroshi Seno, Kenji Kawada, Manabu Muto	2
7	Synthetic Lethality with Trifluridine/Tipiracil and Checkpoint Kinase 1 Inhibitor for Esophageal Squamous Cell Carcinoma 2020 ·Molecular Cancer Therapeutics ·Shinya Ohashi, Osamu Kikuchi, Yukie Nakai, (unknown), Tomoki Saito, Yuki Kondo, Yoshihiro Yamamoto, (unknown), (unknown), (unknown), Hiroshi Tsukihara, Norihiko Suzuki, Manabu Muto	13
8	Cancer of unknown primary with EGFR mutation successfully treated with targeted therapy directed by clinical next-generation sequencing: a case report 2020 ·BMC Cancer ·(unknown), Masashi Kanai, Tadayuki Kou, (unknown), Keitaro Doi, Junichi Matsubara, Shinya Ohashi, Shigemi Matsumoto, Manabu Muto	4
9	Distinct effects of EGFR inhibitors on epithelial- and mesenchymal-like esophageal squamous cell carcinoma cells 2017 ·Journal of Experimental & Clinical Cancer Research ·Masahiro Yoshioka, Shinya Ohashi, (unknown), Yukie Nakai, Osamu Kikuchi, Yusuke Amanuma, Junichi Matsubara, Atsushi Yamada, Shin’ichi Miyamoto, Mitsuteru Natsuizaka, Hiroshi Nakagawa, Tsutomu Chiba, Hiroshi Seno, Manabu Muto	25
10	Protective role of ALDH2 against acetaldehyde-derived DNA damage in oesophageal squamous epithelium 2015 ·Scientific Reports ·Yusuke Amanuma, Shinya Ohashi, Yoshiro Itatani, (unknown), Shun Matsuda, Osamu Kikuchi, Yukie Nakai, Shin’ichi Miyamoto, Tsunehiro Oyama, Toshihiro Kawamoto, Kelly A. Whelan, Hiroshi Nakagawa, Tsutomu Chiba, Tomonari Matsuda, Manabu Muto	35
11	A NOTCH3-Mediated Squamous Cell Differentiation Program Limits Expansion of EMT-Competent Cells That Express the ZEB Transcription Factors 2011 ·Cancer Research ·Shinya Ohashi, Mitsuteru Natsuizaka, Seiji Naganuma, Shingo Kagawa, (unknown), Hiroshi Itoh, Ross A. Kalman, Momo Nakagawa, Douglas S. Darling, Devraj Basu, Phyllis A. Gimotty, Andres J. Klein–Szanto, J. Alan Diehl, Meenhard Herlyn, Hiroshi Nakagawa	89
12	Epidermal Growth Factor Receptor and Mutant p53 Expand an Esophageal Cellular Subpopulation Capable of Epithelial-to-Mesenchymal Transition through ZEB Transcription Factors 2010 ·Cancer Research ·Shinya Ohashi, Mitsuteru Natsuizaka, Gabrielle S. Wong, Carmen Z. Michaylira, Katharine D. Grugan, Douglas B. Stairs, Jiří Kalabis, Maria E. Vega, Ross A. Kalman, Momo Nakagawa, Andres J. Klein–Szanto, Meenhard Herlyn, J. Alan Diehl, Anil K. Rustgi, Hiroshi Nakagawa	126
13	Hypoxia activates the cyclooxygenase-2–prostaglandin E synthase axis 2009 ·Carcinogenesis ·James J. Lee, Mitsuteru Natsuizaka, Shinya Ohashi, Gabrielle S. Wong, Munenori Takaoka, Carmen Z. Michaylira, (unknown), John W. Tobias, Michiyuki Kanai, Yasuhiro Shirakawa, Yoshio Naomoto, Andres J. Klein–Szanto, Volker H. Haase, Hiroshi Nakagawa	102
14	Identification of a novel autoantibody against pancreatic secretory trypsin inhibitor in patients with autoimmune pancreatitis 2007 ·Suizo ·Masanori Asada, Akiyoshi Nishio, Kazushige Uchida, Masahiro Kido, Satoru Ueno, Norimitsu Uza, Keiichi Kiriya, Satoko Inoue, Hiroshi Kitamura, Shinya Ohashi, Hiroyuki Tamaki, Toshiro Fukui, Minoru Matsuura, Kimio Kawasaki, Toshiki Nishi, Norihiko Watanabe, Hiroshi Nakase, Tsutomu Chiba, Kazuichi Okazaki	8
15	Cross‐Primed CD8⁺ Cytotoxic T cells Induce Severe Helicobacter‐associated Gastritis in the Absence of CD4⁺ T cells 2007 ·Helicobacter ·Toshiro Fukui, Akiyoshi Nishio, Kazuichi Okazaki, (unknown), K. Saga, Junya Tanaka, Norimitsu Uza, Satoru Ueno, Masahiro Kido, Shinya Ohashi, Masanori Asada, Hiroshi Nakase, Norihiko Watanabe, Tsutomu Chiba	11
16	Human Thioredoxin-1 Ameliorates Experimental Murine Colitis in Association With Suppressed Macrophage Inhibitory Factor Production 2006 ·Gastroenterology ·Hiroyuki Tamaki, Hajime Nakamura, Akiyoshi Nishio, Hiroshi Nakase, Satoru Ueno, Norimitsu Uza, Masahiro Kido, Satoko Inoue, Sakae Mikami, Masanori Asada, Keiichi Kiriya, Hiroshi Kitamura, Shinya Ohashi, Toshiro Fukui, Kimio Kawasaki, Minoru Matsuura, Yasuyuki Ishii, Kazuichi Okazaki, Junji Yodoi, Tsutomu Chiba	104
17	Clinical Significance of Serum Thioredoxin 1 Levels in Patients with Acute Pancreatitis 2006 ·Pancreas ·Shinya Ohashi, Akiyoshi Nishio, Hajime Nakamura, Masahiro Kido, Keiichi Kiriya, Masanori Asada, Hiroyuki Tamaki, Toshiro Fukui, Kimio Kawasaki, Norihiko Watanabe, Junji Yodoi, Kazuichi Okazaki, Tsutomu Chiba	19
18	A case of autoimmune pancreatitis associated with sclerosing cholangitis, retroperitoneal fibrosis and Sjögren's syndrome 2005 ·Pancreatology ·Toshiro Fukui, Kazuichi Okazaki, (unknown), Shinya Ohashi, Hiroyuki Tamaki, Kimio Kawasaki, Minoru Matsuura, Masanori Asada, Hiroshi Nakase, Yasuaki Nakashima, Akiyoshi Nishio, Tsutomu Chiba	51
19	Immunohistochemical Study of Thyroid Cancer. 1994 ·Practica Oto-Rhino-Laryngologica ·Shinya Ohashi, Fumihisa Hiraide, Tomoyuki Yoshida, (unknown), Hiroyuki Ito, (unknown), Hitoshi Inoue, (unknown), Sotaro Funasaka	3
20	Captopril-stimulated Renal Vein Renin in Hypertensive Patients With or Without Renal Artery Stenosis 1990 ·American Journal of Hypertension ·Fumihiro Tomoda, Masanobu Takata, Shinya Ohashi, (unknown), Kiyoshi Ikeda, (unknown), (unknown), Shigetake Sasayama	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact